
Read More
Emcure Pharmaceuticals Share Price Jumps 4% on Monday; Here's Why...
Emcure Pharmaceuticals will expand the use of Poviztra® for the treatment of MASH following CDSCO ap...

Emcure Pharmaceuticals will expand the use of Poviztra® for the treatment of MASH following CDSCO ap...

Emcure Pharmaceuticals is acquiring the entire 12.05 per cent minority stake in Gennova Biopharmaceu...

Board to Consider Audited Q4FY26 Results and Final Dividend on 5 May; Public Shareholding Rises to 1...